18528731

Source:http://linkedlifedata.com/resource/pubmed/id/18528731

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0032743, umls-concept:C0205420, umls-concept:C0220901, umls-concept:C0332293, umls-concept:C1522609, umls-concept:C1554112, umls-concept:C2349952
pubmed:issue	4
pubmed:dateCreated	2008-6-19
pubmed:abstractText	The purpose of this study was to evaluate the predictive value of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography (FDG-PET) following concurrent chemoradiotherapy (CRT) on survival in patients with carcinoma of the oropharynx (OPC).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-10655437, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-11232954, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-11796235, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-12115349, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-12115386, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-12578453, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-15386332, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-15611393, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-15627258, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-15695042, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-16160644, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-16172571, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-16391182, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17103167, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17237035, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17306956, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17391904, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17438244, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17475963, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17761982, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-8417385, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-9339990
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101125610
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status	MEDLINE
pubmed:issn	1536-1632
pubmed:author	pubmed-author:EnomotoKeisukeK, pubmed-author:HamadaKenichiroK, pubmed-author:HatazawaJunJ, pubmed-author:HiguchiIchiroI, pubmed-author:InoharaHidenoriH, pubmed-author:KuboTakeshiT, pubmed-author:TomiyamaYoichiroY
pubmed:issnType	Print
pubmed:volume	10
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	224-9
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:18528731-Aged, pubmed-meshheading:18528731-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18528731-Carcinoma, Squamous Cell, pubmed-meshheading:18528731-Cisplatin, pubmed-meshheading:18528731-Combined Modality Therapy, pubmed-meshheading:18528731-Disease-Free Survival, pubmed-meshheading:18528731-Drug Administration Schedule, pubmed-meshheading:18528731-Female, pubmed-meshheading:18528731-Fluorodeoxyglucose F18, pubmed-meshheading:18528731-Fluorouracil, pubmed-meshheading:18528731-Follow-Up Studies, pubmed-meshheading:18528731-Humans, pubmed-meshheading:18528731-Male, pubmed-meshheading:18528731-Middle Aged, pubmed-meshheading:18528731-Oropharyngeal Neoplasms, pubmed-meshheading:18528731-Positron-Emission Tomography, pubmed-meshheading:18528731-Predictive Value of Tests, pubmed-meshheading:18528731-Prognosis, pubmed-meshheading:18528731-Radiopharmaceuticals, pubmed-meshheading:18528731-Radiotherapy, Adjuvant, pubmed-meshheading:18528731-Survival Analysis, pubmed-meshheading:18528731-Taxoids
pubmed:articleTitle	Prognostic Value of FDG-PET in patients with oropharyngeal carcinoma treated with concurrent chemoradiotherapy.
pubmed:affiliation	Department of Otolaryngology, Osaka University School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. keisuke.enomoto@tracer.med.osaka-u.ac.jp
pubmed:publicationType	Journal Article, Comparative Study, Evaluation Studies